Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The class 4 semaphorin Sema4D promotes the rapid assembly of GABAergic synapses in rodent hippocampus.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2013

Proper circuit function in the mammalian nervous system depends on the precise assembly and development of excitatory and inhibitory synaptic connections between neurons. Through a loss-of-function genetic screen in cultured hippocampal neurons, we previously identified the class 4 Semaphorin Sema4D as being required for proper GABAergic synapse development. Here we demonstrate that Sema4D is sufficient to promote GABAergic synapse formation in rodent hippocampus and investigate the kinetics of this activity. We find that Sema4D treatment of rat hippocampal neurons increases the density of GABAergic synapses as detected by immunocytochemistry within 30 min, much more rapidly than has been previously described for a prosynaptogenic molecule, and show that this effect is dependent on the Sema4D receptor PlexinB1 using PlxnB1(-/-) mice. Live imaging studies reveal that Sema4D elicits a rapid enhancement (within 10 min) in the rate of addition of synaptic proteins. Therefore, we demonstrate that Sema4D, via PlexinB1, acts to initiate synapse formation by recruiting molecules to both the presynaptic and the postsynaptic terminals; these nascent synapses subsequently become fully functional by 2 h after Sema4D treatment. In addition, acute treatment of an organotypic hippocampal slice epilepsy model with Sema4D reveals that Sema4D rapidly and dramatically alters epileptiform activity, which is consistent with a Sema4D-mediated shift in the balance of excitation and inhibition within the circuit. These data demonstrate an ability to quickly assemble GABAergic synapses in response to an appropriate signal and suggest a potential area of exploration for the development of novel antiepileptic drugs.

Pubmed ID: 23699507 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: F31 NS078901
  • Agency: NINDS NIH HHS, United States
    Id: #T32NS007292
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS065856
  • Agency: NINDS NIH HHS, United States
    Id: #R01NS065856
  • Agency: NINDS NIH HHS, United States
    Id: #P30NS45713
  • Agency: NINDS NIH HHS, United States
    Id: T32 NS007292
  • Agency: NINDS NIH HHS, United States
    Id: #F31NS078901
  • Agency: NIMH NIH HHS, United States
    Id: T32 MH019929
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS045713

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-GluA2/GluR2 Glutamate Receptor Antibody (antibody)

RRID:AB_10674575

This monoclonal targets GluR2 glutamate receptor Gs protein alpha subunit

View all literature mentions

Anti-GluA2/GluR2 Glutamate Receptor Antibody (antibody)

RRID:AB_2232661

This monoclonal targets GluA2/GluR2 glutamate receptor

View all literature mentions